BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2845890)

  • 1. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.
    Sakuma S; Yamamoto M; Kumano Y; Mori R
    Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.
    Tanaka S; Toh Y; Mori R
    Arch Virol; 1993; 131(1-2):61-73. PubMed ID: 8392322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.
    Oliver NM; Collins P; Van der Meer J; Van't Wout JW
    Antimicrob Agents Chemother; 1989 May; 33(5):635-40. PubMed ID: 2546486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency.
    Schinazi RF; del Bene V; Scott RT; Dudley-Thorpe JB
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():127-34. PubMed ID: 3025153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
    Christophers J; Sutton RN
    J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
    Nugier F; Colin JN; Aymard M; Langlois M
    J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
    Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
    J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1.
    Ellis MN; Waters R; Hill EL; Lobe DC; Selleseth DW; Barry DW
    Antimicrob Agents Chemother; 1989 Mar; 33(3):304-10. PubMed ID: 2543278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.
    Hill EL; Hunter GA; Ellis MN
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2322-8. PubMed ID: 1666496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
    Field HJ; Darby G
    Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.
    Erlich KS; Mills J; Chatis P; Mertz GJ; Busch DF; Follansbee SE; Grant RM; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):293-6. PubMed ID: 2536136
    [No Abstract]   [Full Text] [Related]  

  • 18. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.